Leptin Causes Vasodilation in Humans.
スポンサーリンク
概要
- 論文の詳細を見る
<B>Leptin, a product of the ob gene, plays an important role in the regulation of body fat and has been suggested to cause vasodilation in rats. The purpose of this study was to evaluate whether leptin also has a vasodilating effect in humans. Using a strain-gauge plethysmography, we evaluated forearm blood flow (FBF) during intra-arterial infusion of leptin (1, 10 or 100 ng⁄kg⁄min for 5 min) in the absence and presence of the nitric oxide synthase inhibitor <I>N</I><SUP>G</SUP>-monomethyl-L-arginine (L-NMMA; 8 μmol⁄min for 5 min) in ten healthy men (mean age, 23.0±1.2 years). Leptin infusion significantly increased the FBF (8.5±3.8, 20.3±7.0 and 17.7±5.4% at 1, 10 and 100 ng⁄kg⁄min of leptin, respectively; <I>p</I><0.05) and the forearm vascular resistance (FVR; -6.9±3.1, -14.6±4.3 and -13.4±3.9% at 1, 10 and 100 ng⁄kg⁄min of leptin, respectively; <I>p</I><0.05). No significant changes in blood pressure or heart rate were detected during infusion of leptin. The intra-arterial infusion of L-NMMA did not alter the FBF response (6.6±4.9, 22.1±7.5, 13.3±3.2% at 1, 10 and 100 ng⁄kg⁄min of leptin, respectively) or the FVR response (-4.3±4.6, -15.2±5.4, -11.1±2.5% at 1, 10 and 100 ng⁄kg⁄min of leptin, respectively) to leptin. These findings suggest that <I>leptin per</I> se directly causes vasodilation and that leptin-induced vasodilatation is nitric oxide-independent in healthy men. (<I>Hypertens Res</I> 2002; 25: 161-165)</B>
- 日本高血圧学会の論文
日本高血圧学会 | 論文
- Telmisartan treatment decreases Visceral Fat Accumulation and improves Serum Levels of Adiponectin and Vascular Inflammation Markers in Japanese Hypertensive Patients.
- The Effects of Verapamil SR and Bisoprolol on Reducing the Sympathetic Nervous System's Activity.
- The Role of Renal Dopamine in the Reduction of High Blood Pressure by β1-Selective β-Blocker with Intrinsic Sympathomimetic Activity in Spontaneously Hypertensive Rats
- Effects of Long-Term Antihypertensive Therapy on Physical Fitness of Men with Mild Hypertension.
- Prediction of Progression of Left Ventricular Hypertrophy in Mild Hypertension: 5-Year Observations without Pharmacological Intervention.